Prognostic factors and efficacy of GDP-R therapy in refractory/relapsed diffuse large B-cell lymphomas not eligible for high-dose therapy

著录项

• 来源
  《癌症转移与治疗（英文版）》 |2016年第2期|59-63|共5页
• 作者

  Francesco Ghio; Giulia Cervetti; Nadia Cecconi; Matteo Pelosini; Sara Galimberti; Riccardo Morganti; Paola Ferrari;

  展开▼
• 作者单位

  Department of Clinical and Experimental Medicine, University of Pisa, 67-56127 Pisa, Italy;

  Department of Clinical and Experimental Medicine, University of Pisa, 67-56127 Pisa, Italy;

  Department of Clinical and Experimental Medicine, University of Pisa, 67-56127 Pisa, Italy;

  Department of Clinical and Experimental Medicine, University of Pisa, 67-56127 Pisa, Italy;

  Department of Clinical and Experimental Medicine, University of Pisa, 67-56127 Pisa, Italy;

  Department of Oncology, University Hospital of Pisa, 67-56127 Pisa, Italy;

  Department of Clinical and Experimental Medicine, University of Pisa, 67-56127 Pisa, Italy;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词